Electsita-DM Tablet ER
Electsita-DM Tablet ER
Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)
Zitalex-DM Tablet ER
Unilex Lifesciences Pvt Ltd
Dapagliflozin 10mg
Pack Size
1 units
Price
Save ₹22
that's 14% off!
About This Medicine
Product description & overview
Electsita-DM Tablet ER: A Comprehensive Treatment for Diabetes Management
Electsita-DM Tablet ER is a once-daily extended-release medication specifically formulated to manage Type 2 diabetes mellitus (T2DM). This combination therapy incorporates the power of three established antidiabetic agents: Dapagliflozin, Metformin, and Sitagliptin.
* Dapagliflozin (10mg): This SGLT2 inhibitor helps control blood sugar levels by blocking the reabsorption of glucose in the kidneys, promoting its excretion into urine.
* Metformin (500mg): A first-line drug for T2DM, metformin acts on multiple metabolic pathways to lower blood glucose levels and improve insulin sensitivity.
* Sitagliptin (100mg): This DPP-4 inhibitor inhibits the breakdown of incretin hormones, leading to increased insulin secretion and improved glycemic control.
This unique combination offers a comprehensive approach for managing T2DM by addressing multiple aspects of blood sugar regulation. Electsita-DM Tablet ER delivers reliable treatment efficacy with convenience through its once-daily extended-release formula.
Please note: Consult with your healthcare provider for personalized dosage and further information about Electsita-DM Tablet ER. This description is for informational purposes only and should not be construed as medical advice.
Active composition
Metformin 500 mg
+2 more active ingredients
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Sitagliptin
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is not known whether it is safe to consume alcohol with Electsita-DM Tablet ER. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Electsita-DM Tablet ER during pregnancy is not available. Please consult your doctor.
Medical Advice
Driving
Electsita-DM Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Liver
There is limited information available on the use of Electsita-DM Tablet ER in patients with liver disease. Please consult your doctor.
Regular Checkup
Breastfeeding
Information regarding the use of Electsita-DM Tablet ER during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Kidney
Electsita-DM Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Electsita-DM Tablet ER may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Electsita-DM Tablet ER
Products matching your search
Olmezest H 20 Tablet
Olmezest H 20 Tablet
Grinednox-L Capsule
Grinednox-L Capsule
Losanorm 50-H Tablet
Losanorm 50-H Tablet
Glimchek M 2mg/500mg Tablet
Glimchek M 2mg/500mg Tablet
Carispec 6 Capsule
Carispec 6 Capsule
Flunasys-P Tablet SR
Flunasys-P Tablet SR
Calzol-D3 Tablet
Calzol-D3 Tablet
Glz Total Tablet